Finance

Lists
NAN:ASX
Nanosonics Ltd.
2,81 A$
-1,40%
(-0,040) 1D
13 қаз., 16:10:28 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NAN...
Open
2,81 A$
High
2,87 A$
Low
2,81 A$
Mkt. cap
840,66 млн
Avg. vol.
1,10 млн
Volume
1,37 млн
P/E ratio
48,67
52-wk high
4,76 A$
52-wk low
2,64 A$
EPS
0,06 A$
Shares outstanding
299,17 млн
No. of employees
508
Open
2,81 A$
High
2,87 A$
Low
2,81 A$
Mkt. cap
840,66 млн
Avg. vol.
1,10 млн
Volume
1,37 млн
P/E ratio
48,67
52-wk high
4,76 A$
52-wk low
2,64 A$
EPS
0,06 A$
Shares outstanding
299,17 млн
No. of employees
508
News stories
From web sources and news partners
Profile
Nanosonics is an ASX-listed company in the healthcare industry which manufactures and distributes ultrasound probe disinfectors and other related technologies. It has offices in Australia, the U.S. and Canada, the United Kingdom and Europe, employing more than 300 people. The company's Trophon is the product used to reduce the spread of Healthcare Acquired Infections. Its Trophon2 product includes AcuTrace technology, which enables digital record keeping and provides workflows for ultrasound probe high level disinfection. Wikipedia
About Nanosonics Ltd.
CEOMichael Kavanagh
Employees508
Founded2001
HeadquartersСидней, Жаңа Оңтүстік Уэльс, Австралия
SectorMedical device
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
51,12 млн
51,12 млн
50,83 млн
50,83 млн
Cost of goods sold
12,11 млн
12,11 млн
11,43 млн
11,43 млн
Cost of revenue
12,11 млн
12,11 млн
11,43 млн
11,43 млн
Research and development expenses
7,70 млн
7,70 млн
8,19 млн
8,19 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,06 млн
27,06 млн
27,74 млн
27,74 млн
Operating expense
34,44 млн
34,44 млн
35,50 млн
35,50 млн
Total operating expenses
46,56 млн
46,56 млн
46,93 млн
46,93 млн
Operating income
4,56 млн
4,56 млн
3,90 млн
3,90 млн
Other non operating income
-
-
-
-
EBT including unusual items
5,31 млн
5,31 млн
4,74 млн
4,74 млн
EBT excluding unusual items
5,31 млн
5,31 млн
4,76 млн
4,76 млн
Income tax expense
489,50 м.
489,50 м.
649,00 м.
649,00 м.
Effective tax rate
9,22%
9,22%
13,68%
13,68%
Other operating expenses
-323,50 м.
-323,50 м.
-426,00 м.
-426,00 м.
Net income
4,82 млн
4,82 млн
4,10 млн
4,10 млн
Net profit margin
9,43%
9,43%
8,06%
8,06%
Earnings per share
-
-
-
-
Interest and investment income
1,47 млн
1,47 млн
1,43 млн
1,43 млн
Interest expense
-350,00 м.
-350,00 м.
-490,50 м.
-490,50 м.
Net interest expenses
1,12 млн
1,12 млн
938,00 м.
938,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
5,82 млн
5,82 млн
5,24 млн
5,24 млн
Gain or loss from assets sale
-
-
16,50 мың
16,50 мың
AI content may include mistakes. Learn more
Google қолданбалары